Merit Medical Systems Stock Forecast, Price & News

Merit Medical Systems (NASDAQ:MMSI) Frequently Asked Questions

Is Merit Medical Systems a buy right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Merit Medical Systems stock.
View analyst ratings for Merit Medical Systems or view top-rated stocks.

What stocks does MarketBeat like better than Merit Medical Systems?

Wall Street analysts have given Merit Medical Systems a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Merit Medical Systems wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Merit Medical Systems' next earnings date?

Merit Medical Systems is scheduled to release its next quarterly earnings announcement on Wednesday, October 27th 2021.
View our earnings forecast for Merit Medical Systems.

How were Merit Medical Systems' earnings last quarter?

Merit Medical Systems, Inc. (NASDAQ:MMSI) issued its quarterly earnings results on Thursday, July, 29th. The medical instruments supplier reported $0.62 EPS for the quarter, beating the consensus estimate of $0.44 by $0.18. The medical instruments supplier earned $280.33 million during the quarter, compared to the consensus estimate of $251.40 million. Merit Medical Systems had a trailing twelve-month return on equity of 12.42% and a net margin of 2.74%.
View Merit Medical Systems' earnings history.

How has Merit Medical Systems' stock price been impacted by COVID-19?

Merit Medical Systems' stock was trading at $32.88 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MMSI stock has increased by 122.4% and is now trading at $73.13.
View which stocks have been most impacted by COVID-19.

What guidance has Merit Medical Systems issued on next quarter's earnings?

Merit Medical Systems issued an update on its FY 2021 earnings guidance on Thursday, August, 5th. The company provided earnings per share guidance of $2.070-$2.220 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.930. The company issued revenue guidance of $1.06 billion-$1.07 billion, compared to the consensus revenue estimate of $1.01 billion.

What price target have analysts set for MMSI?

8 equities research analysts have issued 1-year price objectives for Merit Medical Systems' shares. Their forecasts range from $60.00 to $83.00. On average, they anticipate Merit Medical Systems' share price to reach $73.13 in the next twelve months. This suggests that the stock has a possible downside of 0.0%.
View analysts' price targets for Merit Medical Systems or view top-rated stocks among Wall Street analysts.

Who are Merit Medical Systems' key executives?

Merit Medical Systems' management team includes the following people:

• Fred P. Lampropoulos, Chairman, President & Chief Executive Officer
• Ronald A. Frost, Chief Operating Officer
• Raul Parra, Chief Financial Officer & Treasurer
• Joseph Pierce, Chief Information Officer
• Jason Treft, Chief Technology Officer

What is Fred P. Lampropoulos' approval rating as Merit Medical Systems' CEO?

158 employees have rated Merit Medical Systems CEO Fred P. Lampropoulos on Glassdoor.com. Fred P. Lampropoulos has an approval rating of 73% among Merit Medical Systems' employees.

Who are some of Merit Medical Systems' key competitors?

Some companies that are related to Merit Medical Systems include Align Technology (ALGN), West Pharmaceutical Services (WST), The Cooper Companies (COO), DENTSPLY SIRONA (XRAY), STAAR Surgical (STAA), Quidel (QDEL), ICU Medical (ICUI), Neogen (NEOG), Haemonetics (HAE), Atrion (ATRI), Cerus (CERS), Meridian Bioscience (VIVO), OraSure Technologies (OSUR), Antares Pharma (ATRS) and Anika Therapeutics (ANIK).
View all of MMSI's competitors.

What other stocks do shareholders of Merit Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), Overstock.com (OSTK), EXFO (EXFO), Energy Transfer (ET), RTI Surgical (RTIX), NVIDIA (NVDA), Under Armour (UA) and Advanced Micro Devices (AMD).

What is Merit Medical Systems' stock symbol?

Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."

Who are Merit Medical Systems' major shareholders?

Merit Medical Systems' stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (13.39%), Vanguard Group Inc. (10.00%), ArrowMark Colorado Holdings LLC (6.98%), William Blair Investment Management LLC (6.11%), Conestoga Capital Advisors LLC (4.20%) and State Street Corp (3.27%). Company insiders that own Merit Medical Systems stock include A Scott Anderson, Brian G Lloyd, David Floyd, David Ming-Teh Liu, Enterprise Associates 14 New, Franklin J Miller, Fred P Lampropoulos, Jill Anderson, Joseph Wright, Lynne Ward, Nolan E Karras, Raul Jr Parra and Ronald Frost.
View institutional ownership trends for Merit Medical Systems.

Which institutional investors are selling Merit Medical Systems stock?

MMSI stock was sold by a variety of institutional investors in the last quarter, including Nuance Investments LLC, Massachusetts Financial Services Co. MA, ArrowMark Colorado Holdings LLC, BlackRock Inc., California Public Employees Retirement System, Aristotle Capital Boston LLC, Rockefeller Capital Management L.P., and Ziegler Capital Management LLC. Company insiders that have sold Merit Medical Systems company stock in the last year include A Scott Anderson, Brian G Lloyd, Fred P Lampropoulos, Jill Anderson, Joseph Wright, Lynne Ward, Raul Jr Parra, and Ronald Frost.
View insider buying and selling activity for Merit Medical Systems or view top insider-selling stocks.

Which institutional investors are buying Merit Medical Systems stock?

MMSI stock was acquired by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Millennium Management LLC, Emerald Mutual Fund Advisers Trust, Invesco Ltd., Morgan Stanley, Morgan Stanley, Dimensional Fund Advisors LP, and Emerald Advisers LLC. Company insiders that have bought Merit Medical Systems stock in the last two years include David Floyd, Enterprise Associates 14 New, and Raul Jr Parra.
View insider buying and selling activity for Merit Medical Systems or or view top insider-buying stocks.

How do I buy shares of Merit Medical Systems?

Shares of MMSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Merit Medical Systems' stock price today?

One share of MMSI stock can currently be purchased for approximately $73.13.

How much money does Merit Medical Systems make?

Merit Medical Systems has a market capitalization of $4.12 billion and generates $963.88 million in revenue each year. The medical instruments supplier earns $-9,840,000.00 in net income (profit) each year or $1.65 on an earnings per share basis.

How many employees does Merit Medical Systems have?

Merit Medical Systems employs 5,989 workers across the globe.

Does Merit Medical Systems have any subsidiaries?

The following companies are subsidiares of Merit Medical Systems: Alveolus Inc., Argon Medical Devices Netherlands BV, BSMD Ventures Inc., BioSphere Medical Inc., BioSphere Medical Japan Inc., BioSphere Medical SA, Brightwater Medical Inc., Brightwater Medical Inc., Cianna Medical Inc., DFINE Inc., Dfine Europe GmbH, Fibrovein Holdings Limited, ITL Healthcare Pty Ltd., IntelliMedical Technologies Pty Ltd., LLC Merit Technologies, Merit Holdings Inc., Merit Maquiladora México S. DE R.L. DE C.V., Merit Medical (NRI) Ireland Limited, Merit Medical Africa (Pty) LTD, Merit Medical Asia Company Limited, Merit Medical Australia Pty Ltd., Merit Medical Austria GmbH, Merit Medical Beijing Co. Ltd., Merit Medical Belgium Sprl, Merit Medical Canada Ltd., Merit Medical Coatings B.V., Merit Medical Comercialização Distribuição Importação e Exportação de Produtos Hospitalares LTDA., Merit Medical Denmark A/S, Merit Medical Egypt LLC, Merit Medical Finland Ltd., Merit Medical France SAS, Merit Medical GmbH, Merit Medical Ireland Ltd., Merit Medical Italy S.R.L., Merit Medical Japan KK, Merit Medical Korea Co. Ltd., Merit Medical ME FZ-LLC, Merit Medical Malaysia Sdn. Bhd, Merit Medical Nederland B.V., Merit Medical New Zealand Limited, Merit Medical Norway AS, Merit Medical Portugal S.A., Merit Medical Singapore Holdings Pte. Ltd, Merit Medical Singapore Pte. Ltd., Merit Medical South Africa (Pty) LTD, Merit Medical Spain S.L.Unipersonal, Merit Medical Switzerland AG, Merit Medical Systems AB, Merit Medical Systems India Private Limited, Merit Medical System’s NRI Limited, Merit Medical Turkey Tıbbi Ürünler Ticaret Anonim Şirketi, Merit Medical UK Limited, Merit Mexico Sales S. de R.L. de C.V., Merit Sensor Systems Inc., STD Pharmaceutical (Ireland) Limited, STD Pharmaceutical Products Limited, Thomas Medical Products Inc., Vascular Access Technologies Inc., and Vascular Insights LLC.

When was Merit Medical Systems founded?

Merit Medical Systems was founded in 1987.

What is Merit Medical Systems' official website?

The official website for Merit Medical Systems is www.merit.com.

Where are Merit Medical Systems' headquarters?

Merit Medical Systems is headquartered at 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095.

How can I contact Merit Medical Systems?

Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The medical instruments supplier can be reached via phone at (801) 253-1600 or via email at [email protected].